266 related articles for article (PubMed ID: 15653173)
1. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
[TBL] [Abstract][Full Text] [Related]
2. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
3. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.
Barabash A; Marcos A; Ancín I; Vázquez-Alvarez B; de Ugarte C; Gil P; Fernández C; Encinas M; López-Ibor JJ; Cabranes JA
Neurobiol Aging; 2009 Aug; 30(8):1254-64. PubMed ID: 18078695
[TBL] [Abstract][Full Text] [Related]
4. alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease.
Licastro F; Chiappelli M; Thal LJ; Masliah E
Arch Gerontol Geriatr Suppl; 2004; (9):243-51. PubMed ID: 15207421
[TBL] [Abstract][Full Text] [Related]
5. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998
[TBL] [Abstract][Full Text] [Related]
6. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
8. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
[TBL] [Abstract][Full Text] [Related]
9. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
[TBL] [Abstract][Full Text] [Related]
10. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
11. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.
Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H
Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759
[TBL] [Abstract][Full Text] [Related]
12. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
[TBL] [Abstract][Full Text] [Related]
13. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
14. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
15. [The association between microsatellite polymorphism of alpha 1-antichymotrypsin gene and Alzheimer's disease].
Jiang S; Lin S; Tang G
Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):610-2. PubMed ID: 11715411
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
18. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
[TBL] [Abstract][Full Text] [Related]
19. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]